Casi Site 01 — New York, New York

Casi Site 01 is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Casi Site 01 has participated in 1 clinical trials.

Therapeutic areas: Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma.

Sponsors: CASI Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Casi Site 01?

Casi Site 01 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Casi Site 01 conducted?

Casi Site 01 has 1 clinical trials on record. Their work covers Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma.

Is Casi Site 01 accredited by Crixeo Health?

Casi Site 01 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Casi Site 01?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.